Applied DNA Sciences, Inc.
APDN · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,581 | -$3,336 | -$2,669 | -$3,297 |
| Dep. & Amort. | $78 | $119 | $59 | $77 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $25 | $27 | $29 | $30 |
| Change in WC | $854 | $77 | -$514 | -$194 |
| Other Non-Cash | -$192 | -$71 | -$231 | $134 |
| Operating Cash Flow | -$2,816 | -$3,185 | -$3,326 | -$3,249 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$11 | -$185 | -$117 | -$371 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $21 | $0 | $0 | $0 |
| Investing Cash Flow | $10 | -$185 | -$117 | -$371 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $723 | $899 | $5,798 | -$391 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | -$38,827 | $0 | -$155 |
| Other Fin. Act. | $0 | $38,827 | $509 | $155 |
| Financing Cash Flow | $723 | $899 | $6,306 | -$391 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2,083 | -$2,471 | $2,863 | -$4,011 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,573 | $10,044 | $7,181 | $11,192 |
| End Cash | $5,490 | $7,573 | $10,044 | $7,181 |
| Free Cash Flow | -$2,827 | -$3,370 | -$3,443 | -$3,620 |